1. Home
  2. VIR vs CLFD Comparison

VIR vs CLFD Comparison

Compare VIR & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • CLFD
  • Stock Information
  • Founded
  • VIR 2016
  • CLFD 1979
  • Country
  • VIR United States
  • CLFD United States
  • Employees
  • VIR N/A
  • CLFD N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • CLFD Telecommunications Equipment
  • Sector
  • VIR Health Care
  • CLFD Utilities
  • Exchange
  • VIR Nasdaq
  • CLFD Nasdaq
  • Market Cap
  • VIR 706.4M
  • CLFD 608.6M
  • IPO Year
  • VIR 2019
  • CLFD N/A
  • Fundamental
  • Price
  • VIR $5.65
  • CLFD $44.31
  • Analyst Decision
  • VIR Strong Buy
  • CLFD Strong Buy
  • Analyst Count
  • VIR 8
  • CLFD 3
  • Target Price
  • VIR $30.25
  • CLFD $46.67
  • AVG Volume (30 Days)
  • VIR 1.2M
  • CLFD 128.4K
  • Earning Date
  • VIR 08-04-2025
  • CLFD 08-06-2025
  • Dividend Yield
  • VIR N/A
  • CLFD N/A
  • EPS Growth
  • VIR N/A
  • CLFD N/A
  • EPS
  • VIR N/A
  • CLFD N/A
  • Revenue
  • VIR $20,861,000.00
  • CLFD $178,209,000.00
  • Revenue This Year
  • VIR N/A
  • CLFD $10.77
  • Revenue Next Year
  • VIR $0.62
  • CLFD $14.46
  • P/E Ratio
  • VIR N/A
  • CLFD N/A
  • Revenue Growth
  • VIR N/A
  • CLFD N/A
  • 52 Week Low
  • VIR $4.32
  • CLFD $23.78
  • 52 Week High
  • VIR $14.45
  • CLFD $46.76
  • Technical
  • Relative Strength Index (RSI)
  • VIR 54.74
  • CLFD 62.30
  • Support Level
  • VIR $5.31
  • CLFD $42.16
  • Resistance Level
  • VIR $5.92
  • CLFD $46.76
  • Average True Range (ATR)
  • VIR 0.30
  • CLFD 1.39
  • MACD
  • VIR 0.02
  • CLFD -0.02
  • Stochastic Oscillator
  • VIR 43.69
  • CLFD 63.38

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About CLFD Clearfield Inc.

Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a various products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has international presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.

Share on Social Networks: